
Chipiron is developing scalable MRI technologies with the goal of making MRI 100x more accessible to enable widespread early diagnosis and image-guided therapies for deadly diseases. Their innovative approach leverages ultra-low magnetic fields (<10 mT) to create a light, inexpensive, open full-body MRI machine without compromising image quality. Key technological advancements include a patented low-Tc SQUID volume gradiometer for improved SNR, an AI noise cancellation system, an MRI-compatible cryostat for an ultra-light cooling system, and unconventional low-field AI reconstruction techniques to reduce acquisition times. Chipiron has secured significant funding, including a $17M Series A, and has received grants from EIC Accelerator and France 2030. They were recognized with the 'Innovation of the Year' award at VivaTech 2025 by TechCrunch. Their roadmap includes prototyping in August 2024, achieving clinical-grade image quality by November 2025, and targeting FDA submission by September 2026. The company aims to make MRI as common as blood sampling.

Chipiron is developing scalable MRI technologies with the goal of making MRI 100x more accessible to enable widespread early diagnosis and image-guided therapies for deadly diseases. Their innovative approach leverages ultra-low magnetic fields (<10 mT) to create a light, inexpensive, open full-body MRI machine without compromising image quality. Key technological advancements include a patented low-Tc SQUID volume gradiometer for improved SNR, an AI noise cancellation system, an MRI-compatible cryostat for an ultra-light cooling system, and unconventional low-field AI reconstruction techniques to reduce acquisition times. Chipiron has secured significant funding, including a $17M Series A, and has received grants from EIC Accelerator and France 2030. They were recognized with the 'Innovation of the Year' award at VivaTech 2025 by TechCrunch. Their roadmap includes prototyping in August 2024, achieving clinical-grade image quality by November 2025, and targeting FDA submission by September 2026. The company aims to make MRI as common as blood sampling.
Product: Ultra-low-field (<10 mT) full-body portable MRI using SQUID detectors and lightweight cryostat
Mission: Make MRI ~100x more accessible for early diagnosis and image-guided therapies
Funding: Raised a $17M Series A (Apr 30, 2025) plus multiple public grants (EIC Accelerator, France 2030)
HQ & founding: Paris, France; founded 2020
Increase accessibility of MRI for early disease diagnosis and image-guided therapies by reducing cost, weight, and facility requirements.
2020
Medical Equipment Manufacturing
€2.5M grant + €15M equity
€3.6M
Non-dilutive
$17M
“Multiple public grants and a $17M Series A including participation from public innovation programs and venture investors (e.g., France 2030, EIC Accelerator, Blast. Club)”
| Company |
|---|
Duration : 6 months
March 2026 (Flexible)
Skills & Experience Training/Profile: Medical Imaging / Deep Learning / MRI Undersampling / Contrast Enhancement
Expected skills are python/coding, deep learning and signal processing
Key Responsibilities Producing contrast-enhanced MR images typically requires the injection of a gadolinium-based agent, followed by the acquisition of a fully sampled, high-quality volume. However, that acquisition is most often redundant with other images acquired during the same exam, and sometimes even paired with a non-contrast version of the same sequence. Deep learning and MRI reconstruction theory have opened opportunities to generate synthetic contrast-enhanced images by leveraging non-contrast data together with highly accelerated, noisy contrast acquisitions. Such approaches promise substantial reductions in scan time while preserving contrast dynamics critical for clinical interpretation.
This internship will focus on developing and validating both (1) acceleration/undersampling strategies paired with (2) deep learning reconstruction to recover high-quality contrast-enhanced MRI from a non-contrast image and a strongly accelerated, low SNR contrast-enhanced acquisition.
Who We Are Chipiron is revolutionizing the medical imaging industry by developing light and easily deployable MRI machines powered by an ultra-sensitive quantum detection system. Our mission is to make MRI accessible to everyone, everywhere. We're a team of engineers based in the heart of Paris, and we have only one obsession: building things people want.
Our Culture